共 130 条
[1]
Jimenez SA(2004)Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis Ann Intern Med 140 37-50
[2]
Derk CT(2003)Systemic sclerosis: the susceptible host (genetics and environment) Rheum Dis Clin North Am 29 211-237
[3]
Tan FK(2007)Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database Ann Rheum Dis 66 754-763
[4]
Walker UA(2007)Changes in causes of death in systemic sclerosis, 1972–2002 Ann Rheum Dis 66 940-944
[5]
Tyndall A(2003)Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population Arthritis Rheum 48 2246-2255
[6]
Czirják L(2003)Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma J Rheumatol 30 1782-1787
[7]
Denton C(2005)Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability and depressive symptoms Clin Rheumatol 24 48-54
[8]
Farge-Bancel D(2010)Systemic sclerosis-associated pulmonary arterial hypertension Am J Respir Crit Care Med 181 1285-1293
[9]
Kowal-Bielecka O(2010)Diagnosis and management of pulmonary hypertension in systemic sclerosis Curr Rheumatol Rep 12 8-18
[10]
Steen VD(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43-S54